Verano Holdings (VRNO) Enterprise Value (2021 - 2026)

Verano Holdings' (VRNO) quarterly Enterprise Value came in at -$75.8 million in Q1 2026, up 11.85% year-on-year from -$67.8 million in Q1 2025, and up 10.29% on a QoQ basis from -$84.5 million in Q4 2025.

Verano Holdings (VRNO) Enterprise Value (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Enterprise Value data on file, last reported at -$75.8 million in Q1 2026.

  • On a quarterly basis, Enterprise Value rose 11.85% year-over-year to -$75.8 million in Q1 2026; TTM through Mar 2026 was -$75.8 million, a 11.85% increase from a year earlier, with the FY2025 full-year figure at -$84.5 million, up 5.22% from the prior year.
  • Enterprise Value for Q1 2026 stood at -$75.8 million, up from -$84.5 million in the prior quarter.
  • Over the last five years, Enterprise Value for VRNO reached as high as -$65.2 million in Q3 2024 and fell as low as -$193.8 million in Q1 2024.
  • Historically, Enterprise Value has averaged -$102.2 million across 5 years, with a median of -$87.6 million in 2024.
  • Across the five-year window, Enterprise Value plunged 105.96% in 2023 and jumped 55.63% in 2025, its largest moves.
  • Year by year, Enterprise Value stood at -$84.9 million in 2022, then plunged by 105.96% to -$174.8 million in 2023, then jumped by 48.99% to -$89.2 million in 2024, then gained by 5.22% to -$84.5 million in 2025, then rose by 10.29% to -$75.8 million in 2026.
  • Per Business Quant data, the three most recent Enterprise Value figures were -$75.8 million in Q1 2026, -$84.5 million in Q4 2025, and -$84.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -1.86 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4.05 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -2.15 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -1.32 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -428.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -75.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -75.80 Mn
Dec 31, 2025 -84.50 Mn
Sep 30, 2025 -84.40 Mn
Jun 30, 2025 -70.35 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 -89.15 Mn
Sep 30, 2024 -65.21 Mn
Jun 30, 2024 -130.05 Mn
Mar 31, 2024 -193.80 Mn
Dec 31, 2023 -174.76 Mn
Sep 30, 2023 -129.84 Mn
Jun 30, 2023 -102.58 Mn
Mar 31, 2023 -95.13 Mn
Dec 31, 2022 -84.85 Mn
Sep 30, 2022 -76.42 Mn
Jun 30, 2022 -92.83 Mn
Dec 31, 2021 -97.84 Mn